Drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030 / Roots Analysis

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs<br><br>Roots Analysis is pleased to announce the publication of its recent study, titled, u201cDrug Repurposing Service Providers Market, 2020-2030.u201d<br>For more information please click on the following https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html:<br>https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html<br><br>Other Recent Offerings<br>1.tPeptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030<br>2.tChina Biopharmaceutical Contract Manufacturing Market, 2020-2030<br>3.tAntibody Contract Manufacturing Market, 2020 - 2030<br><br>About Roots Analysis<br>Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If youu2019d like help with your growing business needs, get in touch at info@rootsanalysis.com<br><br>Contact Information<br>Roots Analysis Private Limited<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br>gaurav.chaudhary@rootsanalysis.com<br>

kevin987 + Follow